Abstract
Amblyopia is an additional challenge to the visual rehabilitation of a child with a corneal opacity. Although amblyopia is defined as impaired vision, usually in one eye, that is structurally normal, amblyopia often coexists in a child with a corneal disorder. Key concepts include critical period of visual development, assessment of vision in children, identification of amblyopia risk factors, definition of amblyopia, and treatment options for amblyopia. The critical period of visual development spans birth to about age 10, a time in which proper visual input from each eye is paramount in order to “teach” the visual cortex the characteristics of excellent vision. There are a variety of methods to assess visual acuity; often a decision about visual impairment needs to be made over several office visits to obtain reproducible and accurate information. Amblyogenic risk factors include asymmetric refractive error (anisometropia), high refractive error in both eyes (ametropia), misaligned visual axes (strabismus), and media opacity. In the preverbal child, a decision to treat amblyopia is made on the basis of an identified amblyogenic risk factor or demonstration of asymmetric visual acuity. There may be a difference between the eyes on preferential looking testing or consistent objection to patching one eye versus the other. In the verbal child, amblyopia is confirmed when a two-line or greater difference in vision is identified, despite correction of any refractive error. Familiarity with treatment options, such as glasses, patching, pharmacologic, and optical penalization is crucial to improve vision.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Ghamdi A, Al-Rajhi A, Wagoner MD (2007) Primary pediatric keratoplasty: indications, graft survival, and visual outcome. J AAPOS 11:41–47
Anwar HM, El Danasoury A, Hashem A (2012) Descemet’s stripping automated endothelial keratoplasty for congenital hereditary endothelial dystrophy. Clin Ophthalmol 6:159–163
Beck RW for Pediatric Eye Disease Investigative Group (2002) A Randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120:268–278
Beck RW for Pediatric Eye Disease Investigative Group (2003) A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 110:2075–2087
Colby K (2008) Changing times for pediatric keratoplasty. J AAPOS 12(3):223–224
Cotter SA for Pediatric Eye Disease Investigative Group (2006) Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 113:895–903
Cotter SA, Tarczy-Hornoch K, Song E, Lin J et al (2009) Fixation preference and visual acuity testing in a population-based cohort of preschool children with amblyopia risk factors. Ophthalmology 116:145–153
Cooper LN, Bear MF (2012) The BCM theory of synapse modification at 30: interaction of theory with experiment. Nature 13:798–810
Duffy KR, Mitchell DE (2013) Darkness alters maturation of visual cortex and promotes fast recovery from monocular deprivation. Curr Biol 23:1–5
Ehrlich MI, Reinecke RD, Simon K (1983) Preschool vision screening for amblyopia and strabismus. Programs, methods, guidelines, 1983. Surv Ophthalmol 28(3):145–163
Fahnehjelm KT, Tornquist AL, Winiarski J (2012) Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler). Acta Ophthalmol 90:287–290
Gräf MH, Becker R, Kaufmann H (2000) Lea symbols: visual acuity assessment and detection of amblyopia. Graefe’s Arch Clin Exp Ophthalmol 238:53–58 © Springer-Verlag
Gu B, Son J, Kim M (2011) Amblyopia and strabismus by monocular corneal opacity following suspected epidemic keratoconjunctivitis in infancy. Korean J Ophthalmol 25(4):257–261
Holmes JM for Pediatric Eye Disease Investigative Group (2008) A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology 115:2071–2078
Holmes JM, Melia M, Bradfield YS, Cruz OA et al (2007) Factors associated with recurrence of amblyopia on cessation of patching. Ophthalmology 114:1427–1432
Homes JM, Beck RW, Repka MX, Leske DA et al (2001) The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 119:1345–1353
Homes JM, Lazar EL, Melia BM, Astle WF et al (2011) Effect of age on response to amblyopia treatment in children. Arch Ophthalmol 129(11):1451–1457
Huang C, O’Hara M, Mannis MJ (2009) Primary pediatric keratoplasty: indications and outcomes. Cornea 28(9):1003–1008
Jones SM, Weinstein JM, Cumberland P, Klein N et al (2007) Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis. Ophthalmology 114:2271–2280
Kanpolat A, Ciftci OU (1995) The use of rigid gas permeable contact lenses in scarred corneas. CLAO J 21:64–66
Kollias AN, Spitzlberger GM, Thurau S, Gruterich M et al (2007) Phototherapeutic Keratectomy in Children J Refract Surg 23:703–708
Lee WB, Shtein RM, Kaufman SC, Deng SX et al (2015) Boston keratoprosthesis: outcomes and complications. Ophthalmology 122(7):1504–1511
Li SL, Jost RM, Morale SE, Stager DR et al (2014) A binocular iPad treatment for amblyopic children. Eye 28:1246–1253
Loudon SE, Fronius M, Looman CWN, Awan M et al (2006) Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci 47:4393–4400
Nischal KK (2015) Genetics of congenital corneal opacification—impact on diagnosis and treatment. Cornea 34(s10):s24–s34
Quinn GE, Hertle RW, Schaffer DB (2002) Evaluation of vision and motility in children. In: Katowitz JA (ed) Pediatric oculoplastic surgery. Springer Science+Business Media, New York
Repka MX for Pediatric Eye Disease Investigative Group (2004) A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 111:2076–2085
Repka MX, Holmes JM (2012) Lessons from the amblyopia treatment studies. Ophthalmology 119(4):657–658
Repka MX, Kraker RT, Beck RW, Cotter SA et al (2008) Monocular oral reading performance following amblyopia treatment in children. Am J Ophthalmol 146(6):942–947
Rathi VM, Mandathara PS, Vaddavalli PK, Srikanth D et al (2012) Fluid filled scleral contact lens in pediatric patients: challenges and outcome. Contact Lens & Anterior Eye 35:189–192
Rocio Arce Gonzalez M, Navas A, Haber A, Ramirez-Luquin T et al (2013) Ocular dermoids: 116 consecutive cases. Eye & Contact Lens 39:188–191
Scheiman MM for Pediatric Eye Disease Investigative Group (2005) Randomized trial of treatment of amblyopia in children aged 7 to 17 Years. Arch Ophthalmol 123:437–447
Segev F, Assia EI, Harizman N, Barequet I et al (2007) Corneal laceration by sharp objects in children seven years of age and younger. Cornea 26:319–323
Wiesel TN, Hubel DH (1963) Single-cell responses in striate cortex of kittens deprived of vision in one eye. J Neurophysiol 26:1003–1017
Ying G, Maguire MG, Cyert LA, Ciner E et al (2014) Prevalence of vision disorders by racial and ethnic group among children participating in head start. Ophthalmology 121(3):630–636
Compliance with Ethical Requirements
Melanie Kazlas, MD declares that she has no conflict of interest. The author for this article carried out no human or animal studies.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kazlas, M. (2017). Corneal Diseases in Children: Amblyopia Management. In: Colby, K. (eds) Corneal Diseases in Children. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-55298-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-55298-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55296-5
Online ISBN: 978-3-319-55298-9
eBook Packages: MedicineMedicine (R0)